David Farabee, Ph.D.


Professor, Psychiatry and Biobehavioral Sciences

Member, Integrated Substance Abuse Program

Contact Information

Work Phone Number: 310.267.5535


David Farabee, Ph.D. is professor-in-residence at the University of California, Los Angeles Semel Institute and Director of the Integrated Substance Abuse Programs (ISAP) Juvenile Justice Research Group. Prior to this he served as lead analyst for criminal justice research at the Texas Commission on Alcohol and Drug Abuse (1992-1995), and as Assistant Professor of Psychiatry and Research Scientist at the University of Kentucky Center on Drug and Alcohol Research (1995-1997). He has published in the areas of substance abuse, adult and juvenile crime, HIV/AIDS, and offender treatment, was co-editor of the books Treatment of Drug Offenders (2002; New York: Springer) and Treating Addicted Offenders: A Continuum of Effective Practices, Volumes I and II (2004, 2007; New York: Civic Research Institute), author of, Rethinking Rehabilitation: Why Can?t We Reform Our Criminals? (2005; Washington, D.C.: AEI Press), and is co-editor of the Offender Substance Abuse Report.


A selected list of publications:

Farabee David, Zhang Sheldon, Yang Joy   A preliminary examination of offender needs assessment: are all those questions really necessary? Journal of psychoactive drugs, 2011; Suppl 7: 51-7.
Nyamathi Adeline, Leake Barbara, Albarran Cynthia, Zhang Sheldon, Hall Elizabeth, Farabee David, Marlow Elizabeth, Marfisee Mary, Khalilifard Farinaz, Faucette Mark   Correlates of depressive symptoms among homeless men on parole Issues in mental health nursing, 2011; 32(8): 501-11.
Farabee David, Hawken Angela, Griffith Peter   Tracking and incentivizing substance abusers in longitudinal research: results of a survey of National Institute on Drug Abuse-funded investigators Journal of addiction medicine, 2011; 5(2): 87-91.
Peng Eugene Yu-Chang, Yeh Ching-Ying, Lyu Shu-Yu, Morisky Donald E, Chen Yi-Ming Arthur, Lee Ming-Been, Farabee David, Malow Robert M   Prevalence and correlates of lifetime suicidal ideation among HIV-infected male inmates in Taiwan AIDS care, 2010; 22(10): 1212-20.
Peng Eugene Yu-Chang, Lee Ming-Been, Morisky Donald Edward, Yeh Ching-Ying, Farabee David, Lan Yu-Ching, Chen Yi-Ming Arthur, Lyu Shu-Yu   Psychiatric morbidity in HIV-infected male prisoners Journal of the Formosan Medical Association = Taiwan yi zhi, 2010; 109(3): 177-84.
Prendergast Michael, Greenwell Lisa, Farabee David, Hser Yih-Ing   Influence of perceived coercion and motivation on treatment completion and re-arrest among substance-abusing offenders The journal of behavioral health services & research, 2009; 36(2): 159-76.
Burdon William M, Dang Jeff, Prendergast Michael L, Messina Nena P, Farabee David   Differential effectiveness of residential versus outpatient aftercare for parolees from prison-based therapeutic community treatment programs Substance abuse treatment, prevention, and policy, 2007; 2(2): 16.
Grella Christine E, Greenwell Lisa, Prendergast Michael, Farabee David, Hall Elizabeth, Cartier Jerome, Burdon William   Organizational characteristics of drug abuse treatment programs for offenders Journal of substance abuse treatment, 2007; 32(3): 291-300.
Cartier Jerome, Farabee David, Prendergast Michael L   Methamphetamine use, self-reported violent crime, and recidivism among offenders in California who abuse substances Journal of interpersonal violence, 2006; 21(4): 435-45.
Farabee David, Shen Haikang   Antipsychotic medication adherence, cocaine use, and recidivism among a parolee sample Behavioral sciences & the law, 2004; 22(4): 467-76.
Farabee David, Shen Haikang, Sanchez Sylvia   Program-level predictors of antipsychotic medication adherence among parolees International journal of offender therapy and comparative criminology, 2004; 48(5): 561-71.
Hser Yih-Ing, Teruya Cheryl, Evans Elizabeth A, Longshore Douglas, Grella Christine, Farabee David   Treating drug-abusing offenders. Initial findings from a five-county study on the impact of California's Proposition 36 on the treatment system and patient outcomes Evaluation review, 2003; 27(5): 479-505.
Messina Nena, Farabee David, Rawson Richard   Treatment responsivity of cocaine-dependent patients with antisocial personality disorder to cognitive-behavioral and contingency management interventions Journal of consulting and clinical psychology, 2003; 71(2): 320-9.
Farabee David, Rawson Richard, McCann Michael   Adoption of drug avoidance activities among patients in contingency management and cognitive-behavioral treatments Journal of substance abuse treatment, 2002; 23(4): 343-50.
Farabee David, Prendergast Michael, Cartier Jerome   Alcohol & drug abuse: alcohol, the "Un-Drug" Psychiatric services (Washington, D.C.), 2002; 53(11): 1375-6.
Rawson Richard A, Huber Alice, McCann Michael, Shoptaw Steven, Farabee David, Reiber Chris, Ling Walter   A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence Archives of general psychiatry, 2002; 59(9): 817-24.
Leukefeld Carl G, Logan T K, Farabee David, Clayton Richard   Drug use and AIDS: estimating injection prevalence in a rural state Substance use & misuse, 2002; 37(5-7): 767-82.
Farabee David, Prendergast Michael, Cartier Jerome   Methamphetamine use and HIV risk among substance-abusing offenders in California Journal of psychoactive drugs, 2002; 34(3): 295-300.